Q32 Bio

Cambridge, United States

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

May 2026

Post-IPO Equity

Top Investors

RA Capital ManagementOrbiMedAbingworthOUP (Osage University Partners)Sanofi Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Q32 Bio's investors?

Q32 Bio's investors include RA Capital Management, OrbiMed, Abingworth, OUP (Osage University Partners), Sanofi Ventures.

Where is Q32 Bio headquartered?

Q32 Bio is headquartered in Cambridge, United States.

What does Q32 Bio do?

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

What stage is Q32 Bio at?

Q32 Bio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 27, 2026.

MLA

"Q32 Bio — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/q32-bio. Accessed June 3, 2026.

APA

VCBacked. (2026). Q32 Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/q32-bio

Wikipedia (cite web)

{{cite web |title=Q32 Bio — Funding & Investors |url=https://www.vcbacked.co/company/q32-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 27, 2026.